Regulatory Pathways & Market Access for Cell Therapies

This conference provides a comprehensive exploration of cell therapies, examining their potential in regenerative medicine, regulatory challenges, market access barriers, and global harmonisation efforts. Key comparative frameworks across regions are discussed alongside future directions, including innovative funding and technological advancements. It emphasises the importance of unified guidelines and international collaborations to ensure equitable access and effective regulation. Attendees...